Pharma & Healthcare – the latest on the FDA data breach, big pharma and more.
Big Data, Big Pharma, Big Privacy Catastrophe by Michael Fertik Published on Forbes.com
Companies are actively, aggressively targeting you using your own personal data, without your knowledge or permission. That’s not good for your privacy, but it’s hardly news – except when it’s the healthcare industry… [ Read More ]
Hacked off: Congress members, PhRMA urge an outside audit of the FDA data breach by Eric Palmer Published on Reuters.com
Clinical trial data, launch plans and manufacturing processes are among a drugmaker’s most prized secrets, sometimes protected by patents and key to the success of a blockbuster. So it is no wonder that pharma companies are fretting after hackers got into the FDA computer system… [ Read More ]
Pharma firms likely to get DCGI relief for selling analgin-based drugs by Sushmi Dey Published on Business-Standards.com
Drug makers may soon be able to resume sale of popular pain-relief drug analgin, which was banned by the government earlier this year. The country’s top drug regulator – Drugs Controller General of India (DCGI) – is considering recommendations by its advisory body to revoke the suspension of sale of analgin based medicines in the country.
Live Industry News
Follow @ACI_Pharma & @ACI_Health
Join ACI Pharmaceuticals/Biotech/Life Sciences Experts Group
Join ACI Healthcare: Legal, Regulatory, and Compliance Experts Group
Related Events
For the complete list of all Pharma upcoming events: Click Here
For the complete list of all Healthcare upcoming events: Click Here
To download past Pharma conference materials: Click Here
To download past Healthcare conference materials: Click Here